Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma

NCT00314873 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT00314873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00314873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma
Lead sponsor
Indiana University
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2006
Completion date
March 31, 2011
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thymic carcinoma